Ontario, Canada (CU)_ Immunocore, which is a late-stage biotechnology firm creating a unique class of bispecific T cell receptor (TCR) bispecific immunotherapies for the treatment of a variety of diseases, including…
Immunocore and Medison Pharma collaborate to market Tebentafusp in Canada
- Advertisement -
(adsbygoogle = window.adsbygoogle || []).push({});


